间质干细胞市场－全球产业规模、份额、趋势、机会和预测，按产品与服务、工作流程、类型、分离来源、适应症、应用、地区和竞争细分，2020 年至 2030 年预测

2024年，全球间质干细胞 (MSC) 市场规模达27.1亿美元，预计2030年将以8.54%的复合年增长率成长。随着再生医学的快速发展、临床试验活动的增加以及人们对MSC治疗潜力认识的不断提高，该市场正日益受到关注。 MSC以其能够分化成骨骼、软骨和脂肪组织等多种细胞类型而闻名，在治疗多种疾病方面展现出良好的前景。其免疫调节和抗发炎特性，加上低免疫原性，使其适用于骨科、神经内科、心臟病学和自体免疫疾病。不断增加的研究投入和有利的人口趋势（包括人口老化和慢性病发病率的上升），进一步推动了市场的发展。 MSC 的应用范围不断扩大，涵盖皮肤病学和肿瘤学等新兴领域，而技术创新和不断扩大的临床研究凸显了 MSC 在治疗和研究领域的潜力。

关键市场驱动因素

慢性病盛行率上升

主要市场挑战

监管挑战

主要市场趋势

技术进步

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：顾客之声

第五章：全球间质干细胞市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 依产品和服务 {产品（细胞和细胞系、试剂盒、培养基和试剂、其他）、服务}
  • 依工作流程（细胞采购与分离、培养与冷冻保存、分化、特性化）
  • 按类型（自体、同种异体）
  • 依分离来源（骨髓、脐带血、週边血、输卵管、胎儿肝臟、肺臟、脂肪组织）
  • 按适应症（骨骼和软骨修復、心血管疾病、发炎和免疫疾病、肝病、癌症、移植物抗宿主疾病、其他）
  • 按应用（疾病建模、药物开发与发现、干细胞库、组织工程、毒理学研究、其他）
  • 按地区
  • 按公司分类（2024）
• 市场地图

第六章：北美间质干细胞市场展望

• 市场规模和预测
• 市场占有率和预测
• 北美：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第七章：欧洲间质干细胞市场展望

• 市场规模和预测
• 市场占有率和预测
• 欧洲：国家分析
  • 德国
  • 英国
  • 义大利
  • 法国
  • 西班牙

第八章：亚太间质干细胞市场展望

• 市场规模和预测
• 市场占有率和预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：南美洲间质干细胞市场展望

• 市场规模和预测
• 市场占有率和预测
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第 10 章：中东和非洲间质干细胞市场展望

• 市场规模和预测
• 市场占有率和预测
• MEA：国家分析
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第 11 章：市场动态

• 驱动程式
• 挑战

第 12 章：市场趋势与发展

• 合併与收购
• 产品开发
• 最新动态

第 13 章：全球间质干细胞市场：SWOT 分析

第 14 章：竞争格局

• Thermo Fisher Scientific, Inc
• Cell Applications, Inc
• Axol Biosciences Ltd
• Cytori Therapeutics Inc
• STEMCELL Technologies
• Cyagen Biosciences
• Celprogen Inc
• BrainStorm Cell Limited
• Stemedica Cell Technologies Inc
• Merck KGaA (MilliporeSigma)
• PromoCell GmbH

第 15 章：策略建议

第16章调查会社について・免责事项

The Global Mesenchymal Stem Cells (MSCs) Market was valued at USD 2.71 billion in 2024 and is projected to grow at a CAGR of 8.54% through 2030. This market is gaining traction due to rapid advancements in regenerative medicine, increased clinical trial activity, and rising awareness of the therapeutic potential of MSCs. Known for their ability to differentiate into various cell types such as bone, cartilage, and adipose tissues, MSCs have shown promise in treating a wide range of medical conditions. Their immunomodulatory and anti-inflammatory properties, combined with low immunogenicity, make them suitable for applications in orthopedics, neurology, cardiology, and autoimmune diseases. Increasing research investments and favorable demographic trends, including an aging population with rising incidences of chronic conditions, are further propelling the market. The scope of MSC applications continues to broaden, encompassing emerging areas such as dermatology and oncology, while technological innovations and expanding clinical studies underline the potential for MSCs in both therapeutic and research domains.

Key Market Drivers

Rising Prevalence of Chronic Diseases

The growing burden of chronic illnesses such as diabetes, cardiovascular diseases, neurodegenerative conditions, and arthritis is significantly driving demand for mesenchymal stem cell-based therapies. As these long-term diseases impose substantial health and economic burdens globally, MSCs offer a regenerative and immunomodulatory approach that addresses underlying tissue damage and inflammation. Their application in chronic disease management is supported by increasing interest in cell-based therapies that promote healing and reduce dependency on symptomatic treatments. The World Health Organization attributes approximately 71% of global deaths to chronic diseases, underscoring the urgent need for innovative therapies like MSCs, which are becoming integral to modern medical approaches.

Key Market Challenges

Regulatory Challenges

Navigating the regulatory environment presents a key challenge for the MSC market. Regulations vary significantly across regions, affecting the approval, manufacturing, and commercialization of MSC-based products. Adhering to Good Manufacturing Practices (GMP) and gaining regulatory approvals can be time-consuming and financially burdensome. The lack of globally harmonized standards also complicates market entry for developers and manufacturers. As the demand for MSC therapies rises, the development of streamlined and unified regulatory pathways will be critical to facilitating wider access and accelerating growth in the global market.

Key Market Trends

Technological Advancements

Technological innovations are transforming the MSC landscape, enabling more efficient and scalable production, enhanced therapeutic efficacy, and targeted delivery. Advances in bioreactor technology, 3D scaffolds, and microfluidic systems have improved the reproducibility and yield of MSC cultures. Tools like CRISPR-Cas9 are being used to genetically modify MSCs to enhance regenerative or immunological capabilities. Progress in biomaterials and drug delivery platforms allows for precise MSC deployment, improving clinical outcomes. Automation and robotic systems are streamlining MSC manufacturing, while imaging techniques like MRI and bioluminescent imaging provide real-time tracking of therapeutic cells. These advancements collectively support the expansion of MSC-based applications and ensure consistency in product quality, aiding in broader adoption across healthcare systems.

Key Market Players

• Thermo Fisher Scientific, Inc
• Cell Applications, Inc
• Axol Biosciences Ltd
• Cytori Therapeutics Inc
• STEMCELL Technologies
• Cyagen Biosciences
• Celprogen Inc
• BrainStorm Cell Limited
• Stemedica Cell Technologies Inc
• Merck KGaA (MilliporeSigma)
• PromoCell GmbH

Report Scope:

In this report, the Global Mesenchymal Stem Cells Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Mesenchymal Stem Cells Market, By Product & Services:

• Product
• Services

Mesenchymal Stem Cells Market, By Workflow:

• Cell Sourcing & Isolation
• Culture & Cryopreservation
• Differentiation
• Characterization

Mesenchymal Stem Cells Market, By Type:

• Autologous
• Allogeneic

Mesenchymal Stem Cells Market, By Source of Isolation:

• Bone Marrow
• Cord Blood
• Peripheral Blood
• Fallopian Tube
• Fetal Liver
• Lung
• Adipose Tissues

Mesenchymal Stem Cells Market, By Indication:

• Bone And Cartilage Repair
• Cardiovascular Disease
• Inflammatory And Immunological Diseases
• Liver Diseases
• Cancer
• GvHD
• Others

Mesenchymal Stem Cells Market, By Application:

• Disease Modelling
• Drug Development & Discovery
• Stem Cell Banking
• Tissue Engineering
• Toxicology Studies
• Others

Mesenchymal Stem Cells Market, By Region:

• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Mesenchymal Stem Cells Market.

Available Customizations:

Global Mesenchymal Stem Cells market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

4. Voice of Customer

5. Global Mesenchymal Stem Cells Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product & Services {Products (Cells & Cell Lines, Kits, Media, & Reagents, Others), Services}
  • 5.2.2. By Workflow (Cell Sourcing & Isolation, Culture & Cryopreservation, Differentiation, Characterization)
  • 5.2.3. By Type (Autologous, Allogeneic)
  • 5.2.4. By Source of Isolation (Bone Marrow, Cord Blood, Peripheral Blood, Fallopian Tube, Fetal Liver, Lung, Adipose Tissues)
  • 5.2.5. By Indication (Bone and Cartilage Repair, Cardiovascular Disease, Inflammatory And Immunological Diseases, Liver Diseases, Cancer, GvHD, Others)
  • 5.2.6. By Application (Disease Modelling, Drug Development & Discovery, Stem Cell Banking, Tissue Engineering, Toxicology Studies, Others)
  • 5.2.7. By Region
  • 5.2.8. By Company (2024)
• 5.3. Market Map

6. North America Mesenchymal Stem Cells Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product & Services
  • 6.2.2. By Workflow
  • 6.2.3. By Type
  • 6.2.4. By Source of Isolation
  • 6.2.5. By Indication
  • 6.2.6. By Application
  • 6.2.7. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Mesenchymal Stem Cells Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product & Services
      • 6.3.1.2.2. By Workflow
      • 6.3.1.2.3. By Type
      • 6.3.1.2.4. By Source of Isolation
      • 6.3.1.2.5. By Indication
      • 6.3.1.2.6. By Application
  • 6.3.2. Canada Mesenchymal Stem Cells Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product & Services
      • 6.3.2.2.2. By Workflow
      • 6.3.2.2.3. By Type
      • 6.3.2.2.4. By Source of Isolation
      • 6.3.2.2.5. By Indication
      • 6.3.2.2.6. By Application
  • 6.3.3. Mexico Mesenchymal Stem Cells Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product & Services
      • 6.3.3.2.2. By Workflow
      • 6.3.3.2.3. By Type
      • 6.3.3.2.4. By Source of Isolation
      • 6.3.3.2.5. By Indication
      • 6.3.3.2.6. By Application

7. Europe Mesenchymal Stem Cells Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product & Services
  • 7.2.2. By Workflow
  • 7.2.3. By Type
  • 7.2.4. By Source of Isolation
  • 7.2.5. By Indication
  • 7.2.6. By Application
  • 7.2.7. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Mesenchymal Stem Cells Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product & Services
      • 7.3.1.2.2. By Workflow
      • 7.3.1.2.3. By Type
      • 7.3.1.2.4. By Source of Isolation
      • 7.3.1.2.5. By Indication
      • 7.3.1.2.6. By Application
  • 7.3.2. United Kingdom Mesenchymal Stem Cells Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product & Services
      • 7.3.2.2.2. By Workflow
      • 7.3.2.2.3. By Type
      • 7.3.2.2.4. By Source of Isolation
      • 7.3.2.2.5. By Indication
      • 7.3.2.2.6. By Application
  • 7.3.3. Italy Mesenchymal Stem Cells Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecasty
      • 7.3.3.2.1. By Product & Services
      • 7.3.3.2.2. By Workflow
      • 7.3.3.2.3. By Type
      • 7.3.3.2.4. By Source of Isolation
      • 7.3.3.2.5. By Indication
      • 7.3.3.2.6. By Application
  • 7.3.4. France Mesenchymal Stem Cells Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product & Services
      • 7.3.4.2.2. By Workflow
      • 7.3.4.2.3. By Type
      • 7.3.4.2.4. By Source of Isolation
      • 7.3.4.2.5. By Indication
      • 7.3.4.2.6. By Application
  • 7.3.5. Spain Mesenchymal Stem Cells Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product & Services
      • 7.3.5.2.2. By Workflow
      • 7.3.5.2.3. By Type
      • 7.3.5.2.4. By Source of Isolation
      • 7.3.5.2.5. By Indication
      • 7.3.5.2.6. By Application

8. Asia-Pacific Mesenchymal Stem Cells Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product & Services
  • 8.2.2. By Workflow
  • 8.2.3. By Type
  • 8.2.4. By Source of Isolation
  • 8.2.5. By Indication
  • 8.2.6. By Application
  • 8.2.7. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Mesenchymal Stem Cells Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product & Services
      • 8.3.1.2.2. By Workflow
      • 8.3.1.2.3. By Type
      • 8.3.1.2.4. By Source of Isolation
      • 8.3.1.2.5. By Indication
      • 8.3.1.2.6. By Application
  • 8.3.2. India Mesenchymal Stem Cells Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product & Services
      • 8.3.2.2.2. By Workflow
      • 8.3.2.2.3. By Type
      • 8.3.2.2.4. By Source of Isolation
      • 8.3.2.2.5. By Indication
      • 8.3.2.2.6. By Application
  • 8.3.3. Japan Mesenchymal Stem Cells Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product & Services
      • 8.3.3.2.2. By Workflow
      • 8.3.3.2.3. By Type
      • 8.3.3.2.4. By Source of Isolation
      • 8.3.3.2.5. By Indication
      • 8.3.3.2.6. By Application
  • 8.3.4. South Korea Mesenchymal Stem Cells Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product & Services
      • 8.3.4.2.2. By Workflow
      • 8.3.4.2.3. By Type
      • 8.3.4.2.4. By Source of Isolation
      • 8.3.4.2.5. By Indication
      • 8.3.4.2.6. By Application
  • 8.3.5. Australia Mesenchymal Stem Cells Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product & Services
      • 8.3.5.2.2. By Workflow
      • 8.3.5.2.3. By Type
      • 8.3.5.2.4. By Source of Isolation
      • 8.3.5.2.5. By Indication
      • 8.3.5.2.6. By Application

9. South America Mesenchymal Stem Cells Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product & Services
  • 9.2.2. By Workflow
  • 9.2.3. By Type
  • 9.2.4. By Source of Isolation
  • 9.2.5. By Indication
  • 9.2.6. By Application
  • 9.2.7. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Mesenchymal Stem Cells Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product & Services
      • 9.3.1.2.2. By Workflow
      • 9.3.1.2.3. By Type
      • 9.3.1.2.4. By Source of Isolation
      • 9.3.1.2.5. By Indication
      • 9.3.1.2.6. By Application
  • 9.3.2. Argentina Mesenchymal Stem Cells Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product & Services
      • 9.3.2.2.2. By Workflow
      • 9.3.2.2.3. By Type
      • 9.3.2.2.4. By Source of Isolation
      • 9.3.2.2.5. By Indication
      • 9.3.2.2.6. By Application
  • 9.3.3. Colombia Mesenchymal Stem Cells Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product & Services
      • 9.3.3.2.2. By Workflow
      • 9.3.3.2.3. By Type
      • 9.3.3.2.4. By Source of Isolation
      • 9.3.3.2.5. By Indication
      • 9.3.3.2.6. By Application

10. Middle East and Africa Mesenchymal Stem Cells Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product & Services
  • 10.2.2. By Workflow
  • 10.2.3. By Type
  • 10.2.4. By Source of Isolation
  • 10.2.5. By Indication
  • 10.2.6. By Application
  • 10.2.7. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Mesenchymal Stem Cells Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product & Services
      • 10.3.1.2.2. By Workflow
      • 10.3.1.2.3. By Type
      • 10.3.1.2.4. By Source of Isolation
      • 10.3.1.2.5. By Indication
      • 10.3.1.2.6. By Application
  • 10.3.2. Saudi Arabia Mesenchymal Stem Cells Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product & Services
      • 10.3.2.2.2. By Workflow
      • 10.3.2.2.3. By Type
      • 10.3.2.2.4. By Source of Isolation
      • 10.3.2.2.5. By Indication
      • 10.3.2.2.6. By Application
  • 10.3.3. UAE Mesenchymal Stem Cells Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product & Services
      • 10.3.3.2.2. By Workflow
      • 10.3.3.2.3. By Type
      • 10.3.3.2.4. By Source of Isolation
      • 10.3.3.2.5. By Indication
      • 10.3.3.2.6. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition
• 12.2. Product Development
• 12.3. Recent Developments

13. Global Mesenchymal Stem Cells Market: SWOT Analysis

14. Competitive Landscape

• 14.1. Thermo Fisher Scientific, Inc
  • 14.1.1. Business Overview
  • 14.1.2. Age Group Offerings
  • 14.1.3. Recent Developments
  • 14.1.4. Key Personnel
  • 14.1.5. SWOT Analysis
• 14.2. Cell Applications, Inc
• 14.3. Axol Biosciences Ltd
• 14.4. Cytori Therapeutics Inc
• 14.5. STEMCELL Technologies
• 14.6. Cyagen Biosciences
• 14.7. Celprogen Inc
• 14.8. BrainStorm Cell Limited
• 14.9. Stemedica Cell Technologies Inc
• 14.10. Merck KGaA (MilliporeSigma)
• 14.11. PromoCell GmbH

15. Strategic Recommendations

16. About Us & Disclaimer